Doptelet

Medicinal product

(Invented) name

Doptelet

Active substance (s)

Avatrombopagas

Strength

20 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

B02BX08, Avatrombopag

Marketing authorisation holder

Swedish Orphan Biovitrum AB (publ), Švedija

Date of authorisation

2019-06-20

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Avatrombopagas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
101986	88088	1088088	lizdinė plokštelė	N10		Receptinis	EU/1/19/1373/001	Netiekiama	-	-	No	-	-
101987	88089	1088089	lizdinė plokštelė	N15		Receptinis	EU/1/19/1373/002	Netiekiama	-	-	No	-	-
105686	91786	1091786	lizdinė plokštelė	N30		Receptinis	EU/1/19/1373/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2019-06-20	Registruotas